• Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus
1994 …2021

Research activity per year

If you made any changes in Pure these will be visible here soon.
Filter
Chapter

Search results

  • 2016

    Polymeric nanoparticles and cancer: Lessons learnt from CRLX101

    Gritli, I., Garmey, E., Eliasof, S., Tellez, A., Davis, M. E. & Yun, Y., 2016, Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation. 51 ed. Royal Society of Chemistry, Vol. 2016-January. p. 199-232 34 p. (RSC Drug Discovery Series; vol. 2016-January, no. 51).

    Research output: Chapter in Book/Report/Conference proceedingChapter

    3 Citations (Scopus)
  • 2009

    Alternative splicing as a therapeutic target for human diseases

    Dery, K. J., Gusti, V., Gaur, S., Shively, J. E., Yen, Y. & Gaur, R. K., Dec 1 2009, Therapeutic Applications of RNAi: Methods and Protocols. Reidhaar-Olson, J. & Rondinone, C. (eds.). p. 127-144 18 p. (Methods in Molecular Biology; vol. 555).

    Research output: Chapter in Book/Report/Conference proceedingChapter

    10 Citations (Scopus)
  • 2008

    Redox property of ribonucleotide reductase small subunit M2 and p53R2

    Liu, X., Xue, L. & Yen, Y., Dec 1 2008, Advanced Protocols in Oxidative Stress I. Armstrong, D., Armstrong, D. & Armstrong, D. (eds.). p. 195-206 12 p. (Methods in Molecular Biology; vol. 477).

    Research output: Chapter in Book/Report/Conference proceedingChapter

    17 Citations (Scopus)
  • 2005

    8 Growth arrest DMA damage-inducible gene 45 β in human hepatocellular carcinoma

    Yen, Y., Dec 1 2005, Molecular Genetics, Liver Carcinoma, and Pancreatic Carcinoma. Hayat, M. A. (ed.). p. 207-215 9 p. (Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas; vol. 3).

    Research output: Chapter in Book/Report/Conference proceedingChapter